Načítá se...
Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort
OBJECTIVE: Pretreatment HIV-drug resistance (PDR, HIVDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) is increasing globally. NNRTIs continue to be used as first-line antiretroviral therapy (ART) in some communities due to the cost of dolutegravir-based ART or dolutegravir-associated...
Uloženo v:
| Vydáno v: | AIDS |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8284934/ https://ncbi.nlm.nih.gov/pubmed/32205723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002524 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|